CLPTM1L-ARFGEF2 Fusion FISH Probe
The CLPTM1L-ARFGEF2 Fusion FISH Probe is used to confirm a fusion of the CLPTM1L and ARFGEF2 genes. The fusion of the CLPTM1L and ARFGEF2 genes has been associated with Head And Neck Squamous Cell Carcinoma . These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CLPTM1L-ARFGEF2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CLPTM1L-ARFGEF2-20-AQAQ | 20 (40 μL) | 200 μL |
|
ARFGEF2 Gene Summary
ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Jul 2008]
Gene Name: ADP Ribosylation Factor Guanine Nucleotide Exchange Factor 2
Chromosome: CHR20: 47538274 -47653230
Locus: 20q13.13
CLPTM1L Gene Summary
The protein encoded by this gene is a membrane protein whose overexpression in cisplatin-sensitive cells causes apoptosis. Polymorphisms in this gene have been reported to increase susceptibility to several cancers, including lung, pancreatic, and breast cancers. [provided by RefSeq, Nov 2015]
Gene Name: CLPTM1 Like
Chromosome: CHR5: 1317999 -1345002
Locus: 5p15.33
Gene Diseases
The CLPTM1L ARFGEF2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Head And Neck Squamous Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|